Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01383980 · ClinicalTrials.gov registry record · NA
Trial of Continuous Versus Interrupted Feeding for Intubated Intensive Care Unit Patients
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT01383980: Completed NA study, sponsored by Oregon Health and Science University.
NCT01383980 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01383980, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
Surgical patients fed up until the point of surgery will have safe delivery of more calories compared to a group whose feeding is held at midnight prior to surgery.
Primary Outcome
The total number of calories subject consume while receiving tube feeding.
Interventions
- DIETARY_SUPPLEMENT Continuous Tube Feedings
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2011-08 |
| Est. Completion | 2017-08 |
| Phase | NA |
What the finished NCT01383980 record still lists
NCT01383980 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Continuous Tube Feedings is the first listed.
NCT01383980 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01383980 about?
NCT01383980 is a clinical study titled "Trial of Continuous Versus Interrupted Feeding for Intubated Intensive Care Unit Patients". Surgical patients fed up until the point of surgery will have safe delivery of more calories compared to a group whose feeding is held at midnight prior to surgery.
What is the current status of trial NCT01383980?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2011-08. Estimated completion is 2017-08.
What interventions are being tested in trial NCT01383980?
The interventions under investigation include: Continuous Tube Feedings (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01383980?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01383980's enrollment target sits among peer trials
36 1541st of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia